Bunamiodyl

CHEMBL2110636 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
639.0 g/mol
LogP
4.6
Phase
4

An iodinated contrast agent historically used for cholecystography, a type of X-ray imaging of the gallbladder. It was administered orally and concentrated in the bile to visualize the gallbladder and bile ducts. It has been replaced by ultrasound and other modern imaging techniques.

Masse moléculaire

639,0100 g/mol

LogP

4,60

TPSA

66,40 Ų

Règle des 5 de Lipinski

Conforme

Mécanisme d'action

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCC(=O)Nc1c(I)cc(I)c(/C=C(\CC)C(=O)O)c1I

InChI

InChI=1S/C15H16I3NO3/c1-3-5-12(20)19-14-11(17)7-10(16)9(13(14)18)6-8(4-2)15(21)22/h6-7H,3-5H2,1-2H3,(H,19,20)(H,21,22)/b8-6+

Molecular Formula

C15H16I3NO3

HBD / HBA

2 / 3

Liaisons Rotatives

6

Atomes Lourds

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

An iodinated contrast agent historically used for cholecystography, a type of X-ray imaging of the gallbladder. It was administered orally and concentrated in the bile to visualize the gallbladder and bile ducts. It has been replaced by ultrasound and other modern imaging techniques.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Bunamiodyl is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110636. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6436657. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.